AI-generated summary
This overview describes photobiomodulation, a noninvasive light therapy using red and near-infrared wavelengths, and its proposed mechanism of action. The authors report that light is absorbed by mitochondrial cytochrome C oxidase, which alters ATP, reactive oxygen species and calcium levels and activates downstream signaling pathways. The authors state that therapy effectiveness depends on treatment parameters and that the therapy is generally well tolerated.
- Wavelengths
- 620, 700, 400, 1440 nm
- Limits stated in the abstract
- The abstract is a general overview and reports no specific clinical sample, outcomes or quantitative findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 620-700 nm, 400-700 nm, 700-1440 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Reactive oxygen species, Adenosine triphosphate, Near-infrared, Cytochrome c oxidase, Phototherapy, Fluence, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.